Hepatitis C virus incidence among young street-involved IDUs in relation to injection experience

Drug and Alcohol Dependence

Volumn 102, Issue 1-3, 2009, Pages 158-161

  Roy, Élise ^a,b   Boudreau, Jean François ^a   Boivin, Jean François ^b,c  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

^b Gouvernement du Quebec   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Hepatitis C; Incidence; Initiation; Injection; Street youth; Young injection drug users

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DRUG ABUSE; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HUMAN; IMMUNOASSAY; INCIDENCE; INFECTION SENSITIVITY; INJECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; SEROCONVERSION;

ADOLESCENT; ADULT; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; POISSON DISTRIBUTION; PROSPECTIVE STUDIES; QUEBEC; QUESTIONNAIRES; SUBSTANCE ABUSE, INTRAVENOUS; YOUNG ADULT;

HEPATITIS C VIRUS;

EID: 67349119488     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.01.006     Document Type: Article

References (26)

1. Australia Government, Department of Health and Ageing, 2006. Hepatitis C Virus Projections Working Group: Estimates and Projections of the Hepatitis C Virus Epidemic in Australia 2006. http://www.health.gov.au/internet/main/publishing.nsf/Content/phd-hepc-e stimates-project-06-l (accessed on September 23, 2008).
2. Crofts N., Stewart T., Hearne P., Ping X.Y., Breschkin A.M., and Locarnini S.A. Spread of bloodborne viruses among Australian prison entrants. Br. Med. J. 310 (1995) 285-288
3. Des Jarlais D.C., Diaz T., Perlis T., Vlahov D., Maslow C., Latka M., Rockwell R., Edwards V., Friedman S.R., Monterroso E., Williams I., and Garfein R.S. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. Am. J. Epidemiol. 157 (2003) 467-471
4. Garfein R.S., Doherty M.C., Monterroso E.R., Thomas D.L., Nelson K.E., and Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. J. Acquir. Immune Defic. Syndr. 18 Suppl. 1 (1998) S11-S19
5. Garfein R.S., Vlahov D., Galai N., Doherty M.C., and Nelson K.E. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses. Am. J. Public Health 86 (1996) 655-661
6. Hagan H., and Des Jarlais D.C. HIV and HCV infection among injecting drug users. Mt. Sinai J. Med. 67 (2000) 423-428
7. Hagan H., McGough J.P., Thiede H., Weiss N.S., Hopkins S., and Alexander E.R. Syringe exchange and risk of infection with Hepatitis B and C viruses. Am. J. Epidemiol. 149 (1999) 203-213
8. Hagan H., Thiede H., and Des Jarlais D.C. Hepatitis C virus infection among injection drug users. Survival analysis of time to seroconversion. Epidemiology 15 (2004) 543-549
9. Hagan H., Thiede H., Weiss N.S., Hopkins S.G., Duchin J.S., and Alexander E.R. Sharing of drug preparation equipment as a risk factor for hepatitis C. Am. J. Public Health 91 (2001) 42-46
10. Hahn J.A., Page-Shafer K., Lum P.J., Bourgois P., Stein E., Evans J.L., Busch M.P., Tobler L.H., Phelps B., and Moss A.R. Hepatitis C virus seroconversion among young injection drug users: relationships and risks. J. Infect. Dis. 186 (2002) 1558-1564
11. Haley N., Roy E., Leclerc P., Boudreau J.-F., and Boivin J.-F. HIV risk profile of male street youth involved in survival sex. Sex. Transm. Infect. 80 (2004) 526-530
12. Heintges T., and Wands J.R. Hepatitis C virus: epidemiology and transmission. Hepatology 26 (1997) 521-526
13. Judd A., Hutchinson S., Wadd S., Hickman M., Taylor A., Jones S., Parry J.V., Cameron S., Rhodes T., Ahmed S., Bird S., Fox R., Renton A., Stimson G.V., and Goldberg D. Prevalence of, and risk factors for, hepatitis C virus infection among recent initiates to injecting in London and Glasgow: cross sectional analysis. J. Viral. Hepat. 12 (2005) 655-662
14. Klein J.P., and Moeschberger M.L. Survival Analysis. Techniques for Censored and Truncated Data (1997), Springer-Verlag, New York, NY
15. Maher L., Jalaludin B., Chant K.G., Jayasuriya R., Sladden T., Kaldor J.M., and Sargent P.L. Incidence and risk factors for hepatitis C seroconversion in injecting drug users in Australia. Addiction 101 (2006) 1499-1508
16. Maher L., Li J., Jalaludin B., Chant K.G., and Kaldor J.M. High hepatitis C incidence in new injecting drug users: A policy failure?. Aust. N. Z. J. Public Health 31 (2007) 30-35
17. Miller C.L., Johnston C., Spittal P.M., Li K., LaLiberté N., Montaner J.S.G., and Schechter M.T. Opportunities for prevention: Hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 36 (2002) 737-742
18. National Institutes of Health, 2002. Management of Hepatitis C: 2002. http://consensus.nih.gov/2002/2002HepatitisC2002116PDF.pdf (accessed on September 23, 2008).
19. O'Connell J.M., Kerr T., Li K., Tyndall M.W., Hogg R.S., Montaner J.S., and Wood E. Requiring help injecting independently predicts incident HIV infection among injection drug users. J. Acquir. Immune Defic. Syndr. 40 (2005) 83-88
20. Rothman K.J., and Greenland S. Modern Epidemiology. 2nd ed. (1998), Lippincott-Raven, Philadelphia, PA
21. Roy K., Hay G., Andragetti R., Taylor A., Goldberg D., and Wiessing L. Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature. Epidemiol. Infect. 129 (2002) 577-585
22. Thorpe L.E., Ouellet L.J., Hershow R., Bailey S.L., Williams I.T., Williamson J., Monterroso E.R., and Garfein R.S. Risk of hepatitis C virus infection among young adult injection drug users who share injection equipment. Am. J. Epidemiol. 155 (2002) 645-653
23. Thorpe L.E., Ouellet L.J., Levy J.R., Williams I.T., and Monterroso E.R. Hepatitis C virus infection: prevalence, risk factors, and prevention opportunities among young injection drug users in Chicago, 1997-1999. J. Infect. Dis. 182 (2000) 1588-1594
24. van Beek I., Dwyer R., Dore G.J., Luo K., and Kaldor J.M. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study. Br. Med. J. 137 (1998) 433-437
25. van den Berg C.H.S.B., Smit C., Bakker M., Geskus R.B., Berkhout B., Jurriaans S., Coutinho R.A., Wolthers K.C., and Prins M. Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users. Eur. J. Epidemiol. 22 (2007) 183-193
26. Vlahov D., Fuller C.M., Ompad D.C., Galea S., and Des Jarlais D.C. Updating the infection risk reduction hierarchy: preventing transition into injection. J. Urban Health 81 (2004) 14-19